Matthews International Announces Third Quarter Fiscal 2021 Earnings Release and Conference Call

Written by Customer Service on July 8, 2021. Posted in Public Companies.

PITTSBURGH, July 08, 2021 (GLOBE NEWSWIRE) — Matthews International Corporation (Nasdaq GSM: MATW) today announced plans to release its third quarter fiscal year 2021 earnings results after the market closes on Thursday, July 29, 2021. The Company will host a conference call and webcast to review the financial and operating results for the period and discuss its outlook. Participating in the call will be Joseph C. Bartolacci, President and CEO, and Steven F. Nicola, Chief Financial Officer. A question-and-answer session will follow. Third Quarter Fiscal Year 2021 Conference Call Friday, July 30, 2021 9:00 a.m. Eastern Time Phone: 201-689-8471 Webcast and accompanying slide presentation: www.matw.com As soon as available after the call, a transcript of the call will be posted in the Investor Relations section of the...

California Water Service Group Schedules Second Quarter 2021 Earnings Results Announcement and Teleconference

Written by Customer Service on July 8, 2021. Posted in Public Companies.

SAN JOSE, Calif., July 08, 2021 (GLOBE NEWSWIRE) — California Water Service Group (NYSE: CWT) today announced that its second quarter 2021 earnings results will be released at 9:00 a.m. ET with its teleconference to follow at 11:00 a.m. ET on Thursday, July 29, 2021. All stockholders and interested investors are invited to listen to the teleconference. Please dial in at least 15 minutes in advance to ensure a timely connection to the call. The 2021 second quarter conference call may be accessed by dialing 1-833-832-5130 or 1-509-844-0151 and keying in ID# 3119418. A replay of the call will be available from 2:00 p.m. ET on Thursday, July 29, 2021 through September 29, 2021, at 1-855-859-2056 or 1-404-537-3406, ID# 3119418. The replay will also be available under the investor relations tab at www.calwatergroup.com. The call will...

Cyclerion Therapeutics and Beacon Biosignals Announce Expanded Strategic Partnership

Written by Customer Service on July 8, 2021. Posted in Public Companies.

Beacon Biosignals and Cyclerion to extend and expand partnership on data collection and analytics strategy to facilitate development of Cyclerion investigational therapeutics for neurological diseases associated with cognitive impairment CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two companies. This collaboration is expected to identify disease-relevant biomarkers to refine patient selection and endpoints to guide the clinical development of Cyclerion’s investigational therapeutics for neurological diseases associated with cognitive impairment. Beacon Biosignals’ EEG neurobiomarker platform is engineered to discover and scale new clinical paradigms for patients with neurological and...

Brookfield Renewable Partners 2021 Second Quarter Conference Call and Webcast for Investors and Analysts

Written by Customer Service on July 8, 2021. Posted in Public Companies.

Date: Thursday, August 5, 2021Time: 11:00 a.m. (Eastern Time) BROOKFIELD, News, July 08, 2021 (GLOBE NEWSWIRE) — You are invited to participate in Brookfield Renewable Partners’ 2021 Second Quarter Conference Call and Webcast on Thursday, August 5, 2021 at 11:00 a.m. (Eastern Time) to discuss results and current business initiatives with members of senior management. These results will be released on Thursday, August 5, 2021 at approximately 7:00 a.m. and will be available on our website at http://bep.brookfield.com under “Press Releases”. To participate in the conference call, please dial 1-866-688-9430 toll-free at approximately 10:50 a.m. If calling from outside Canada or the U.S., dial 1-409-216-0817. When prompted, enter the conference ID, 7282435. The conference call will also be webcast live at https://edge.media-server.com/mmc/p/i5rvi5om,...

Ovid Therapeutics Strengthens Board & Leadership Team to Focus Efforts on Expanding Its Neurosciences Capabilities

Written by Customer Service on July 8, 2021. Posted in Public Companies.

Dr. Michael Poole to Join the Board of Directors Dr. Claude Nicaise Appointed Head of R&D and Jason Tardio Appointed Chief Operating Officer Dr. Amit Rakhit to Join the Scientific and Clinical Advisory Board NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID) today announced appointments to its board of directors and leadership team as well as a realignment of its workforce to focus on early-stage development activities, including the build out of its neuroscience programs. The changes are part of a broad initiative to reshape Ovid to achieve its strategic goals and advance next-generation medicines that transform the lives of people with intractable, rare neurological diseases. “Ovid has a considerable capital base, exciting research programs and active business development efforts. We are taking...

Monaker Group Completes Name Change to NextPlay Technologies, and Will Trade Under Nasdaq Ticker Symbol, NXTP

Written by Customer Service on July 8, 2021. Posted in Public Companies.

SUNRISE, FL, July 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Monaker Group, Inc. (NASDAQ: MKGI) (NASDAQ: NXTP), a technology solutions company building a digital business ecosystem for digital advertisers, consumers, video gamers and travelers, will begin trading at the opening of the market tomorrow, July 9, 2021, under its new name, NextPlay Technologies, Inc. and Nasdaq ticker symbol, NXTP. The new stock CUSIP number will be 65344G102. The new name follows the earlier announced completed acquisition of HotPlay Enterprise Limited, provider of in-game, AI-powered advertising technology and online-to-offline couponing solutions with a hyper-local insertion capability. The acquisition further expanded NextPlay’s growing digital ecosystem that now includes AI-powered AdTech, Digital Connected TV (with reach to more than...

Allena Pharmaceuticals, Inc. to Present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference

Written by Customer Service on July 8, 2021. Posted in Public Companies.

NEWTON, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that Louis Brenner, M.D., President and Chief Executive Officer, will present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference. Management will also be available for 1×1 meetings on July 13-14, 2021. Details for the presentation are below: Ladenburg Thalmann Healthcare Conference Presentation Date: Tuesday, July 13, 2021 Time: 5:00 – 5:25 pm ET Track: 2 Webcast Link: https://wsw.com/webcast/ladenburg7/alna/2382292 A replay of the webcast will also be available on Allena’s website for approximately...

National Bank Holdings Corporation Announces Date for 2021 Second Quarter Earnings Release

Written by Customer Service on July 8, 2021. Posted in Public Companies.

DENVER, July 08, 2021 (GLOBE NEWSWIRE) — National Bank Holdings Corporation (NYSE: NBHC) expects to report its second quarter financial results after the markets close on Monday, July 26, 2021. Management will host a conference call to review the results at 11:00 a.m. Eastern Time on Tuesday, July 27, 2021. Interested parties may listen to this call by dialing (888) 394-8218/ 0800 358 6377 (United Kingdom) using the confirmation code of 8424776 and asking for the NBHC Q2 2021 Earnings Call. A telephonic replay of the call will be available beginning approximately four hours after the call’s completion through August 1, 2021, by dialing (888) 203-1112 using the confirmation code of 8424776. The earnings release and an on-line replay of the call will also be available on the Company’s website at www.nationalbankholdings.com by visiting...

Image Sensing Systems Wrong Way Alerting Solution Helps Save Lives on Roadways

Written by Customer Service on July 8, 2021. Posted in Public Companies.

ST. PAUL, Minn., July 08, 2021 (GLOBE NEWSWIRE) — Image Sensing Systems, Inc.(NASDAQ: ISNS), the industry-leading developer of Intelligent Transportation Systems (ITS) above-ground detection technology, today announces the release of their next generation Wrong Way Alerting Solution that includes Alert Trust™, a service which delivers an unparalleled level of efficiency through alert accuracy. Every wrong way driving event starts with a mistake that can result in a severe or fatal accident. How these events are resolved no longer need to be left up to chance. The Wrong Way Alerting Solution goes beyond traditional detection of the wrong way driver and provides transportation agencies with deeper insights that can help in developing effective strategies and resolutions to this challenging problem. It starts with analytics and data...

Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease

Written by Customer Service on July 8, 2021. Posted in Public Companies.

CAMBRIDGE, Mass. and NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) — Today, access to the world’s largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequence analysis collaboration between AbbVie (NYSE: ABBV), Biogen Inc. (Nasdaq: BIIB) and Pfizer (NYSE: PFE). Managed by the Broad Institute of MIT and Harvard, the browser gives access to results from analyses of whole exome sequencing data from 300,000 UK Biobank research participants. These genetic data have been paired with detailed health information to create this browsable resource. The collaboration between AbbVie, Biogen and Pfizer to make these data available highlights the importance of working together to advance science. The companies engaged with the Broad Institute for data processing...

Day: July 8, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice